definiens: means, with respect to an entity ’s obligations under this Agreement relating to BioNTechProducts or Co - Development Products, those efforts and resources that are consistent with the exercise of customary scientific andbusiness practices as applied in the pharmaceutical industry for a company of a similar stage and size as the entity and having similarresources ( viewed in relation to such Party and all of its Affiliates plus, in the case of Genevant, [ * * * ] ( applying that term to [ * * * ] mutatismutandis as with respect to Genevant ) ) for Development, regulatory, Manufacturing and Commercialization activities conducted with respectto products at a similar stage of Development or Commercialization and having similar commercial potential, taking into account relativesafety and efficacy, product profile, the regulatory environment, payors ’ policies and regulations, competitiveness of the marketplace and themarket potential of such products, the nature and extent of market exclusivity, including patent coverage and regulatory data protection, price and reimbursement status, and all other relevant commercial, technical, legal, scientific, regulatory, or medical factors